ALDX Operating Cash Flow Growth
Aldeyra Therapeutics Inc · Operating Cash Flow Growth
ALDX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported46.36%period ending
ALDX Quarterly Cash from Operations YoY % (-274.78% → 46.36%)
Year-over-year change
High-resolution chart · PNG
ALDX operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 46.3553% | |
| 59.0199% | |
| 55.974% | |
| 11.9562% | |
| 35.3068% | |
| -25.0385% | |
| -2,505.2524% | |
| 0.623% | |
| 0.9997% | |
| -5.6002% | |
| 104.4558% | |
| 36.1796% | |
| 33.0723% | |
| 26.6397% | |
| 2.993% | |
| -49.0878% | |
| -119.9932% | |
| 4.4429% | |
| -39.2019% | |
| -35.2171% | |
| -19.7032% | |
| 12.2919% | |
| 25.9134% | |
| 24.986% | |
| 40.8389% | |
| -21.5942% | |
| -40.8895% | |
| -8.1467% | |
| -105.1155% | |
| -58.8011% | |
| -58.7755% | |
| -63.3939% | |
| -17.5793% | |
| -89.9902% | |
| -28.3685% | |
| -34.3089% | |
| -63.2861% | |
| 6.572% | |
| -31.0526% | |
| -21.5277% | |
| -103.0885% | |
| -143.0417% | |
| -85.6471% | |
| -138.108% | |
| -79.0842% | |
| -73.3131% | |
| -167.3013% | |
| -134.3336% | |
| -207.6421% | |
| -256.9856% | |
| -274.7812% |